Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
new long acting formulation of an old dependable drug
April 28, 2009
RISPERDAL(R) CONSTA(R) Approved in Japan | www.pipelinereview.com
Risperdal has been a good drug for schizophrenia, a most challenging disease for a long time. Other drugs have come along but none have really been found superior in efficacy or side effect profile. The benefit of a long acting formulation is that outpatient care is made easier , reducing compliance issues and therefore controlling the disease far more likely. It is very helpful to be able to have another choice in the armentarium of a drug that doctors know and trust.
No need to lag as the day goes on for sleep apnea, narcolepsy and jet laggers
April 16, 2009
Cephalon to apply for FDA approval for Nuvigil for jet lag | www.reuters.com
An FDA approved alternative to modafinal will soon be available that will allow patients who suffer from sleepiness during the wrong parts of the day . Modafinil is not a scheduled drug like the amphetamines and provided a much needed alternative. Modafinil has been tweaked to armodafinil (Nuvigil is the brand name, to be launched by Cephalon) to provide a longer course of action so that dosing once daily will allow someone to stay alert until it is time for them to get some zzzs when they desire. This will help those who suffer from jet lag, narcolepsy, obstructive sleep apnea, and shift work disorders.
Page : 11 to 2 of 2
February 7, 2012
What do the cloud, collaboration and virtualization have in common?
January 27, 2012
Clinical diagnostic acquisitions dominate 2011 top ten list
January 12, 2012
Gene therapy success threatens drugs for hemophilia and rare diseases
December 13, 2011
Medtech M&A activity accelerates in 2011
November 30, 2011